For the first time, Merck has granted generic manufacturers, including three African companies, permission to produce an investigational monthly HIV prevention pill, alimatravir,…

If all of its National Institutes of Health funding falls away, the country could lose 70% of its medical research capacity

Cancellation letters, which end millions of rands of South African universities’ US-government funded HIV and TB research grants with immediate effect, started to roll in over…

Researchers are calling for more partnerships and funding for malaria programmes, while 2.3-million children in three African countries have already received a jab

The recent announcement of a promising Covid-19 vaccine is good news. But don’t get too excited, cautions Simon Allison: other more affluent countries have already bought up most…

Rhulani Nhlaniki is Pfizer’s cluster lead for sub-Saharan Africa. As Pfizer starts phase III of the clinical trial of their Covid-19 vaccine candidate, he tells Malaikah Bophela…

Despite the long history of medical racism, any potential Covid-19 vaccines must be tested in Africa — but not only on the continent

It is a beacon of hope, yet the state’s cystic fibrosis unit at the Charlotte Maxeke Johannesburg Academic Hospital might be closed.

It’s been a long journey of discovery for the family of a Cape Town girl who suffers from cystinosis.

But some patient groups denounced the trial in its entirety.

A clinical trial which could benefit Aids patients is about to lose its funding because the Medicines Control Council won’t answer its phones.